1-5 of 5
Paula Layton
Close
Sort by
Journal Articles

Incidence, Risks, and Outcomes of Relapse Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma.

Michael R. Bishop, MD, Seth Steinberg, PhD, Nancy M. Hardy, MD, Steven Z. Pavletic, MD, Ronald E. Gress, MD, Rachel B. Salit, MD, Paula Layton, BSN, Daniel H. Fowler, MD
Journal: Blood
Blood (2010) 116 (21): 3451.
https://doi.org/10.1182/blood.V116.21.3451.3451
Published: 2010
Journal Articles

Allogeneic Hematopoetic Transplantation for CLL: Results of Combination Chemotherapy as Pre-Transplant Targeted Lymphocyte Depletion on Disease Response, Donor Chimerism, and Transplantation Outcomes.

Brian C Shaffer, MD, Marko Modric, David Liewehr, MS, Maryalice Stetler-Stevenson, MD, PhD, Diane C Arthur, MD, Seth Steinberg, PhD, Frances T Hakim, PhD, Kelly Bryant, Jeanne Odom, Paula Layton, BSN, Rachel B Salit, MD, Christoph Rader, PhD, Ronald E Gress, MD, Daniel H Fowler, MD, Michael R Bishop, MD, Steven Z Pavletic, MD
Journal: Blood
Blood (2010) 116 (21): 3476.
https://doi.org/10.1182/blood.V116.21.3476.3476
Published: 2010
Journal Articles

Adoptive Transfer of Treg-Depleted Donor Th1 and Th2 Cells Safely Accelerates Alloengraftment After Low-Intensity Chemotherapy

Daniel H. Fowler, MD, Miriam E. Mossoba, Ph.D., Bazetta Blacklock Schuver, Paula Layton, BSN, Frances T Hakim, PhD, Roger Kurlander, MD, Juan Gea-Banacloche, Claude Sportes, Nancy M. Hardy, MD, Steven Z. Pavletic, MD, Seth M. Steinberg, Hanh Khuu, Marianna Sabatino, MD, David Stroncek, MD, Susan Leitman, MD, Scott D Rowley, Michele L Donato, Andre Goy, MD, Thea Friedman, PhD, Robert Korngold, PhD, Andrew L Pecora, Bruce L Levine, PhD, Carl H. June, MD, Ronald E. Gress, MD, Michael R. Bishop, MD
Journal: Blood
Blood (2010) 116 (21): 521.
https://doi.org/10.1182/blood.V116.21.521.521
Published: 2010
Journal Articles

Early Recovery of Thymus-Derived Naìˆve T Cells in Pediatric Patients (pts) Treated with Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NMSCT) for Cancer.

Terry J. Fry, MD, Alison R. Rager, Frances Hakim, PhD, Cynthia Love, Paula Layton, Daniel Fowler, MD, Michael R. Bishop, MD, Ronald Gress, MD, Crystal L. Mackall, MD, Alan S. Wayne, MD
Journal: Blood
Blood (2006) 108 (11): 310.
https://doi.org/10.1182/blood.V108.11.310.310
Published: 2006
Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (SCT) with Pre-Transplant Targeted Immune Depletion Results in Rapid Full Donor Engraftment in Pediatric Patients with Malignancy.

Terry J. Fry, MD, Teresa Cardesa-Salzman, MD, Frances Hakim, PhD, Cynthia Love, R.N., BSN., Paula Layton, R.N., BSN, Ronald Gress, MD, Daniel Fowler, MD, Michael R. Bishop, MD, Crystal L. Mackall, MD, Alan S. Wayne, MD
Journal: Blood
Blood (2005) 106 (11): 3672.
https://doi.org/10.1182/blood.V106.11.3672.3672
Published: 2005